GR3018632T3 - Beta-alethine use in cell culture and therapy. - Google Patents

Beta-alethine use in cell culture and therapy.

Info

Publication number: GR3018632T3
Authority: GR; Greece
Prior art keywords: alethine; beta; therapy; cell culture; treatment
Prior art date: 1990-07-06

Application number

GR960400052T

Other languages

English (en)

Inventor

Galen Daryl Knight

Paul Leslie Mann

Terence Joseph Scallen

Original Assignee

Univ New Mexico

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-06

Filing date

1996-01-10

Publication date

1996-04-30

1996-01-10 Application filed by Univ New Mexico filed Critical Univ New Mexico

1996-04-30 Publication of GR3018632T3 publication Critical patent/GR3018632T3/el

Links

WELIVEBWRWAGOM-UHFFFAOYSA-N 3-amino-n-[2-[2-(3-aminopropanoylamino)ethyldisulfanyl]ethyl]propanamide Chemical compound NCCC(=O)NCCSSCCNC(=O)CCN WELIVEBWRWAGOM-UHFFFAOYSA-N 0.000 title abstract 3
238000004113 cell culture Methods 0.000 title abstract 2
238000002659 cell therapy Methods 0.000 title 1
208000026278 immune system disease Diseases 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
230000004069 differentiation Effects 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000009826 neoplastic cell growth Effects 0.000 abstract 1
230000036448 vitalisation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0093—Purging against cancer cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GR960400052T 1990-07-06 1996-01-10 Beta-alethine use in cell culture and therapy. GR3018632T3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US54910390A	1990-07-06	1990-07-06
US54910490A	1990-07-06	1990-07-06
PCT/US1991/004725 WO1992000960A1 (en)	1990-07-06	1991-07-08	Beta-alethine use in cell culture and therapy

Publications (1)

Publication Number	Publication Date
GR3018632T3 true GR3018632T3 (en)	1996-04-30

Family

ID=27069009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960400052T GR3018632T3 (en)	1990-07-06	1996-01-10	Beta-alethine use in cell culture and therapy.

Country Status (9)

Country	Link
EP (1)	EP0538330B1 (el)
JP (1)	JP3319597B2 (el)
AT (1)	ATE128964T1 (el)
AU (1)	AU646875B2 (el)
DE (1)	DE69113802T2 (el)
DK (1)	DK0538330T3 (el)
ES (1)	ES2080954T3 (el)
GR (1)	GR3018632T3 (el)
WO (1)	WO1992000960A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245561B1 (en)	1990-07-06	2001-06-12	University Of New Mexico	β-alethine use in cell culture and therapy
JP3259960B2 (ja) *	1990-07-06	2002-02-25	ユニバシテイオブニューメキシコ	細胞培養及び治療に有用なビタレテイン
US5643966A (en) *	1990-07-06	1997-07-01	University Of New Mexico	β-alethine as anti-tumor agent
WO1994026259A1 (en) *	1993-05-12	1994-11-24	Oculon Corporation	Chemical prevention or reversal of cataract by phase separation inhibitors
US6007819A (en)	1995-10-17	1999-12-28	Dovetail Technologies, Inc.	Methods of inducing immunity using low molecular weight immune stimulants
WO1999042116A1 (en)	1998-02-24	1999-08-26	Dovetail Technologies Inc.	Novel disulfides and thiol compounds
US6762174B1 (en)	1998-02-24	2004-07-13	Dovetail Technologies, Inc.	Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4552765A (en) *	1982-05-14	1985-11-12	Santen Pharmaceutical Co., Ltd.	Aletheine derivatives
JPS5973515A (ja) *	1982-10-20	1984-04-25	Santen Pharmaceut Co Ltd	肝障害抑制剤

1991
- 1991-07-08 JP JP51211791A patent/JP3319597B2/ja not_active Expired - Fee Related
- 1991-07-08 ES ES91912761T patent/ES2080954T3/es not_active Expired - Lifetime
- 1991-07-08 AU AU82077/91A patent/AU646875B2/en not_active Ceased
- 1991-07-08 EP EP91912761A patent/EP0538330B1/en not_active Expired - Lifetime
- 1991-07-08 WO PCT/US1991/004725 patent/WO1992000960A1/en active IP Right Grant
- 1991-07-08 AT AT91912761T patent/ATE128964T1/de not_active IP Right Cessation
- 1991-07-08 DK DK91912761.3T patent/DK0538330T3/da active
- 1991-07-08 DE DE69113802T patent/DE69113802T2/de not_active Expired - Fee Related
1996
- 1996-01-10 GR GR960400052T patent/GR3018632T3/el unknown

Also Published As

Publication number	Publication date
DK0538330T3 (da)	1996-02-26
EP0538330A1 (en)	1993-04-28
AU8207791A (en)	1992-02-04
JP3319597B2 (ja)	2002-09-03
AU646875B2 (en)	1994-03-10
WO1992000960A1 (en)	1992-01-23
DE69113802D1 (de)	1995-11-16
ES2080954T3 (es)	1996-02-16
JPH05508769A (ja)	1993-12-09
EP0538330A4 (en)	1993-07-07
EP0538330B1 (en)	1995-10-11
DE69113802T2 (de)	1996-05-15
ATE128964T1 (de)	1995-10-15

Similar Documents

Publication	Publication Date	Title
BR9910251A (pt)	2001-01-02	Estimulação hematopoiética
ATE87214T1 (de)	1993-04-15	Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
ES2170096T3 (es)	2002-08-01	Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
ES2077530A1 (es)	1995-11-16	Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
DE69535328D1 (de)	2007-01-18	In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
AU6649996A (en)	1997-02-26	Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
ZA91574B (en)	1991-11-27	Use of n-myristoyl-(s)-phenylalanine for obtaining medicinal products for the treatment of diseases involving myristoylation
ES2151607T3 (es)	2001-01-01	Factor 12 de crecimiento y de diferenciacion.
GR3018632T3 (en)	1996-04-30	Beta-alethine use in cell culture and therapy.
HK1055079A1 (en)	2003-12-24	Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
CA2098113A1 (en)	1992-06-11	Substances of polypeptide nature useful in human therapy
HUT58037A (en)	1992-01-28	Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
AU4482985A (en)	1986-01-16	Pyrro-1-yl-phenyl-dihydropyridazones
AU5781886A (en)	1986-11-27	Process for the in vitro immunization of human splenocytes against tumor associated antigens
ATE141510T1 (de)	1996-09-15	Arzneimittel enthaltend cd14
PH23658A (en)	1989-09-27	Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor
HK1035866A1 (en)	2001-12-14	A complex of alpha-fetoprotein (afp) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
MD1119G2 (ro)	1999-07-31	Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine
DK0539525T3 (da)	2000-04-10	Vitalethein og anvendelse deraf i cellekultur og terapi
GEP20012377B (en)	2001-03-25	Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
EP0278715A3 (en)	1989-03-08	Use of human gamma interferon for treatment of basal cell carcinoma
WO2000022097A3 (en)	2000-08-10	Periferal blood mensenchymal precursor cells
Zamshor et al.	1986	Beef-extract agar with sodium nucleinate as a medium for storage and stabilization of biological properties of shigellas.
BG48924A3 (en)	1991-06-14	Method for preparing of biologically active means
MX9703493A (es)	1997-10-31	Induccion in vitro de celulas dopaminergicas.